| Literature DB >> 27170518 |
Marion R Munk1,2,3, Marco Beck1, Simone Kolb1, Michael Larsen4, Steffen Hamann4, Christophe Valmaggia5, Martin S Zinkernagel1,3,6.
Abstract
PURPOSE: To quantitatively evaluate retinal layer thickness changes in acute macular neuroretinopathy (AMN).Entities:
Keywords: Imaging; Macula
Mesh:
Year: 2016 PMID: 27170518 PMCID: PMC5293849 DOI: 10.1136/bjophthalmol-2016-308367
Source DB: PubMed Journal: Br J Ophthalmol ISSN: 0007-1161 Impact factor: 4.638
Figure 1Multimodal imaging of acute macular neuroretinopathy. (A) Colour photography of the right eye. (B) Colour photography of the left eye. (C) Near-infrared images with characteristic hyporeflective lesions. (D) Fluorescein angiography with early (D1), arteriovenous (D2) and late (D3) phases of the left eye.
Figure 2Retinal layer analysis of acute macular neuroretinopathy (AMN) lesions seen in near-infrared reflectance (NIR) imaging with spectral domain optical coherence tomography (SD-OCT). (A) Representative NIR image with characteristic hyporeflective lesions and the orientation of the scan (green line). (B) SD-OCT through the AMN lesion and (B2) retinal layer segmentation where the yellow line represents the boundary between the inner nuclear layer and the outer plexiform layer (OPL), the white line represents the boundary between the OPL and the outer nuclear layer (ONL) and the blue line represent the boundary between the ONL and the photoreceptor (PR) outer segment layer complex. (C) Box and whisker plots of the OPL (left) and the ONL (right) of the fellow eye (FE) and the AMN lesion (AMN) at baseline (n=11, paired t test, ns=not significant).
Demographics and clinical characteristics of patients with classic acute macular neuroretinopathy (AMN)
| No. | Age | Eye | Study eye | Sex | F/u years | Baseline BCVA | BCVA last visit | Medication taken during onset of symptoms possibly associated with AMN | Associated/causative findings |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 37 | OD | m | 2.2 | None. | Car accident. | |||
| 2 | 25 | OU | f | 0.6 | OD:20/50 | OD:20/25 | None. | Unknown. | |
| 3 | 17 | OS | f | 1.3 | OD:20/16 | OD:20/16 | None. | Unknown. | |
| 4 | 36 | OS | f | 1.1 | None. | SAB, accident. | |||
| 5 | 27 | OS | f | 0.2 | OD:20/20 | OD:20/20 | None. | Unknown. | |
| 6 | 27 | OU | f | 1.4 | None. | Fever 1 day before onset. | |||
| 7 | 25 | OU | f | 0.4 | None. | Viral infection. | |||
| 8 | 24 | OD | f | 0.6 | None. | Unknown. | |||
| 9 | 24 | OS | f | 0.2 | OD:20/20 | OD:20/20 | None. | Unknown. | |
| 10 | 22 | OU | f | 3.7 | OD: 20/20 | OD:20/20 | Oral contraceptives. | Influenza-like symptoms. | |
| 11* | 25 | OU | f | 0.6 | Intravenous rabbit antithymocyte globulin, oral contraceptives. | Oxalosis type 1, H.o. kidney and liver Tx. |
Study eyes are shown in bold.
*Munch et al.26
Eye, eyes presenting with AMN lesions at baseline; study eye, eye included in the analyses; OD, right eye; OS, left eye; OU, both eyes; F/u, follow-up; BCVA, best corrected visual acuity; SAB, subarachnoidal bleeding; H.o., history of; Tx, transplantation.
Figure 3Retinal layer analysis of acute macular neuroretinopathy (AMN) lesions outside the near-infrared reflectance (NIR) imaging lesions with spectral domain optical coherence tomography (SD-OCT). (A1) NIR images with superimposed colour-coded outer plexiform layer (OPL) thickness maps where the black dotted lines represent hyporeflective NIR lesions (top left), NIR images with corresponding hyporeflective lesions (white dotted lines) and area of OPL thickening (red dotted line) (top right), and the corresponding SD-OCT image with enhanced OPL (between blue and yellow line) (bottom). (A2) Box and whisker plots of the OPL (left) and the outer nuclear layer (ONL) (right) of the fellow eye (FE) and the AMN lesion (AMN) at baseline (n=11, paired t test). (B) Near-infrared images of AMN at initial presentation (BL) and after 2 months (BL+2 months) with corresponding SD-OCT images (bottom). There is marked thickening of the OPL (asterisk) in the area of AMN progression.
Mean thickness values and comparison between the study eye and the fellow eye (given in mean±SD) of individual retinal layers at the hyporeflective NIR image AMN lesion and at the area of maximal OPL thickening at baseline and after last follow-up
| Baseline NIR | Follow-up NIR | |||||
|---|---|---|---|---|---|---|
| Fellow | Study | p Value | Fellow | Study | p Value | |
| Retinal thickness (µm) | 337±21 | 316±28 | 339±23 | 313±24 | ||
| INL thickness NIR (µm) | 38±6 | 37±8 | 0.9 | 38±7 | 36±4 | 0.34 |
| OPL thickness NIR (µm) | 33±16 | 45±19 | 0.1 | 34±11 | 42±19 | 0.24 |
| ONL thickness NIR (µm) | 73±17 | 51±21 | 72±17 | 58±14 | 0.1 | |
| PR thickness NIR (µm) | 80±4 | 77±8 | 0.055 | 83±4 | 83±6 | 0.5 |
| Retinal thickness (µm) | 336±26 | 328±22 | 335±31 | 326±25 | 0.29 | |
| INL thickness OPL (µm) | 37±6 | 38±9 | 0.4 | 35±5 | 36±4 | 0.5 |
| OPL thickness OPL (µm) | 39±16 | 50±14 | 0.005* | 38±11 | 48±14 | 0.13 |
| ONL thickness OPL (µm) | 69±16 | 52±16 | 0.002* | 67±19 | 57±14 | 0.3 |
| PR thickness OPL (µm) | 82±3 | 82±4 | 0.8 | 82±3 | 83±3 | 0.1 |
*Statistically significant.
AMN, acute macular neuroretinopathy; INL, inner nuclear layer; NIR, near-infrared reflectance; ONL, outer nuclear layer; OPL, outer plexiform layer; PR, photoreceptor complex.